Results 221 to 230 of about 399,723 (373)

Comparison of Prosigna® Assay and Urokinase Plasminogen Activator/Plasminogen Activator Inhibitor-1 Results in Early-Stage Breast Cancer Patients. [PDF]

Breast Care (Basel)
Rickerl L, Bartsch H, Harbeck N, Hofmann DM, Kolben T, Degenhardt T, Sotlar K, Wuerstlein R.   +7 more
europepmc   +1 more source

Plasminogen Activator Inhibitor-1 and Vitamin D Association in the Overweight and Obese Pediatric Population. [PDF]

Nutrients, 2023
Di Felice G, D'Alessandro A, Pastore A, Mariani M, Fintini D, Aureli A, Pezzi S, Montemari AL, Rocco BB, Borseti A, Onetti Muda A, Manco M, Porzio O.   +12 more
europepmc   +1 more source

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene.

Journal of Clinical Investigation, 1996
D. Eitzman, R. D. McCoy, Xianxian Zheng, W. Fay, Tingliang Shen, D. Ginsburg, R. Simon   +6 more
semanticscholar   +1 more source

Functional Interactions between Sp1 or Sp3 and the Helicase-like Transcription Factor Mediate Basal Expression from the Human Plasminogen Activator Inhibitor-1 Gene [PDF]

, 1999
Hao Ding, Mohammed Abderrafi Benotmane, Guntram Suske, Désiré Collen, Alexandra Belayew   +4 more
openalex   +1 more source

Genetic risk variants implicate impaired maintenance and repair of periodontal tissues as causal for periodontitis—A synthesis of recent findings

Periodontology 2000, EarlyView.
AbstractPeriodontitis is a complex inflammatory disease in which the host genome, in conjunction with extrinsic factors, determines susceptibility and progression. Genetic predisposition is the strongest risk factor in the first decades of life. As people age, chronic exposure to the periodontal microbiome puts a strain on the proper maintenance of ...
Arne S. Schaefer, Luigi Nibali, Noha Zoheir, Niki M. Moutsopoulos, Bruno G. Loos   +4 more
wiley   +1 more source

Targeting autophagy and plasminogen activator inhibitor-1 increases survival and remodels the tumor microenvironment in glioblastoma. [PDF]

J Exp Clin Cancer Res
Shifman SG, O'Connor JL, Radin DP, Sharma A, Infante L, Ferraresso F, Kastrup CJ, Lawrence DA, Tsirka SE.   +8 more
europepmc   +1 more source

The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells.

Journal of Biological Chemistry, 1993
Sally J. DawsonS, Bjorn Wimans, A. Hamsten, F. Green, S. Humphries, A. Henney   +5 more
semanticscholar   +1 more source

Plasminogen activator inhibitor type-1 is a negative regulator of hematopoietic regeneration

, 2014
Abd Aziz Ibrahim, アブドゥル アジズ ビン イブラヒム   +1 more
openalex   +1 more source

Structural and Functional Analysis of the Plasminogen Activator Inhibitor-1 Binding Motif in the Somatomedin B Domain of Vitronectin

, 1996
Gang Deng, Gordon Royle, Soujuan Wang, Karen Crain, David J. Loskutoff   +4 more
openalex   +1 more source

Tranexamic acid dosing in pediatric trauma: Dose simulation based on population pharmacokinetic modeling in adult trauma patients

Transfusion, EarlyView.
Abstract Background Trauma is the most common cause of death in children >1 year of age, with hemorrhage being the most common preventable cause of death after injury. Antifibrinolytics like tranexamic acid (TXA) are a key aspect of trauma management in children, but optimal dosing remains unknown.
Gideon Stitt, Kevin Downes, Athena Zuppa, Christine Leeper, Kevin Watt, Philip Spinella   +5 more
wiley   +1 more source